ArticleProstate international2020

Comparative efficacy and safety profile of 4 vs 8 mg of silodosin once daily usage in patients with benign prostatic hyperplasia-related lower urinary tract symptoms divided into subgroups according to International Prostate Symptom Score severity.

Abdullah Gul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.